Locations:
SearchAdvertisement
Universal testing could reduce expected costs compared to EGFR single gene testing
Research enables precision medicine beyond patients with changed mutational status
We now have an expanded toolbox to extend survival and lessen treatment toxicity
New research provides clinical insight into prognostic factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
On-demand stem cell mobilizer is an effective salvage strategy
Minimal residual disease testing shows promising results
Insights on leveraging collaboration and advocacy to develop and conduct needed trials
Study calls attention to the need for screenings at age 40 or younger
Dispelling myths and sharing practical experiences
Lack of appropriate testing remains a barrier for patients eligible for targeted treatment
Advertisement
Advertisement